Gene · 23091
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of N6-methyladenosine RNA modification in gastric cancer. | Cell Death Discov | 2023 | 37443100 | PubTator, text mining | PubMed |
| Levels and clinical significance of the m6A methyltransferase METTL14 in patients with coronary heart disease. | Front Cardiovasc Med | 2023 | 37441706 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling. | Cell Death Dis | 2023 | 37438359 | PubTator, text mining | PubMed |
| A risk model constructed using 14 N6-methyladenosine-related lncRNAs as a new prognostic marker that correlates with the immunomodulatory effect and drug sensitivity in colorectal cancer. | J Gastrointest Oncol | 2023 | 37435206 | PubTator, text mining | PubMed |
| Analyses of m6A regulatory genes and subtype classification in atrial fibrillation. | Front Cell Neurosci | 2023 | 37435047 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A regulators characterized by the immune microenvironment in Duchenne muscular dystrophy. | J Transl Med | 2023 | 37434186 | PubTator, text mining | PubMed |
| N6-adenosine (m6A) mRNA methylation is required for Tribolium castaneum development and reproduction. | Insect Biochem Mol Biol | 2023 | 37422274 | PubTator, text mining | PubMed |
| A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients. | J Cancer Res Clin Oncol | 2023 | 37421455 | PubTator, text mining | PubMed |
| Construction and validation of stemness-related lncRNA pair signature for predicting prognosis in colorectal cancer. | J Cancer Res Clin Oncol | 2023 | 37410143 | PubTator, text mining | PubMed |
| m6A-related lncRNAs predict prognosis and indicate cell cycle in gastric cancer. | Front Genet | 2023 | 37408779 | PubTator, text mining | PubMed |
| Human RNA Modifications Disease Database (HRMDD): A web resource for the molecular and clinical landscape of RNA modifications in human diseases. | Genes Dis | 2023 | 37397534 | PubTator, text mining | PubMed |
| Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAs. | Front Genet | 2023 | 37396046 | PubTator, text mining | PubMed |
| Epigenetic modification of m6A regulator proteins in cancer. | Mol Cancer | 2023 | 37391814 | PubTator, text mining | PubMed |
| m6A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication. | Viruses | 2023 | 37376680 | PubTator, text mining | PubMed |
| The Roles of Zinc Finger Proteins in Colorectal Cancer. | Int J Mol Sci | 2023 | 37373394 | PubTator, text mining | PubMed |
| Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics. | Cancer Metastasis Rev | 2023 | 37369946 | PubTator, text mining | PubMed |
| Roles and implications of mRNA N6 -methyladenosine in cancer. | Cancer Commun (Lond) | 2023 | 37350762 | PubTator, text mining | PubMed |
| Small RNA modifications: regulatory molecules and potential applications. | J Hematol Oncol | 2023 | 37349851 | PubTator, text mining | PubMed |
| Exploration of m6A methylation regulators as epigenetic targets for immunotherapy in advanced sepsis. | BMC Bioinformatics | 2023 | 37330481 | PubTator, text mining | PubMed |
| Microenvironment modulation by key regulators of RNA N6-methyladenosine modification in respiratory allergic diseases. | BMC Pulm Med | 2023 | 37328853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23091/papers?page=13